Search for Clinical Trial Results

Sponsored By

Charcot-Marie-Tooth Disease Type 1 - 24 Studies Found

Status Study
Not yet recruiting Study Name: Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers
Condition: Charcot-Marie-Tooth Disease Type 1A
Date: 2015-10-30
Interventions:
  • Other: Clinical evaluation
  • Other: electrop
Not yet recruiting Study Name: Correlation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1A
Condition: Charcot-Marie-Tooth Type 1A Neuropathy
Date: 2012-11-16
Active, not recruiting Study Name: Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Condition: Charcot-Marie-Tooth Disease Type 1A
Date: 2015-09-28
Interventions:
  • Drug: PXT3003 dose 1 Liquid or
Active, not recruiting Study Name: Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot−Marie−Tooth Neuropathy Type 1A (CMT1A)
Condition:
  • Charcot-Marie-Tooth Disease
  • Charcot-Marie-Tooth Disease Type 1A
    Date: 2011-01-24
    Interventions:
    • Other: TreSPE

Recruiting Study Name: Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Condition: Charcot-Marie-Tooth Disease, Type IA
Date: 2016-12-26
Interventions: Drug: PXT3003 Liquid oral solution, 5 mL bid for 9 consecutive months
Completed Study Name: Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A
Condition:
  • Charcot-Marie-Tooth Disease
  • Hereditary Neuropathy With Liability to Pressure Palsies
    • Date: 2011-07-20
    Interventions:
    • Drug: PXT3003 Low dose Liquid,
Recruiting Study Name: Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease
Condition: Charcot-Marie-Tooth Disease
Date: 2017-04-12
Interventions: Drug: ACE-083 Part 1 - Recombinant fusion protein. Part 2 - Recombinant fusion protein or buffer solutio
Completed Study Name: High Dose Ascorbic Acid Treatment of CMT1A
Condition: Charcot-Marie-Tooth Disease, Type Ia
Date: 2007-06-08
Interventions:
  • Drug: Ascorbic acid (Vitamin C)

Completed Study Name: Ascorbic Acid Treatment in CMT1A Trial (AATIC)
Condition:
  • Charcot-Marie-Tooth Disease
  • Hereditary Motor and Sensory Neuropathies

Date: 2006-01-03
Interventions:
  • Drug: Placebo Placebo 4 capsul
Recruiting Study Name: SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study
Condition: